|
|
|
Insider
Information: |
Torley Helen |
Relationship: |
Director |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
683,004 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$30,539,335 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
683,004 |
|
|
Total
Value |
$30,539,335 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-28.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Onyx Pharmaceuticals Inc |
ONXX |
EVP, Chief Commercial ... |
2013-10-01 |
0 |
2011-08-29 |
0 |
Premium* |
|
Halozyme Therapeutics Inc |
HALO |
|
2024-02-16 |
676,744 |
2014-09-16 |
0 |
Premium* |
|
Relypsa Inc |
RLYP |
Director |
2016-09-01 |
0 |
2015-06-04 |
0 |
Premium* |
|
Quest Diagnostics Inc |
DGX |
Director |
2021-05-25 |
6,260 |
2018-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HALO |
Halozyme Therapeutics Inc |
President and CEO |
|
2021-08-10 |
4 |
AS |
$40.42 |
$2,055,576 |
D/D |
(50,000) |
537,160 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
President and CEO |
|
2021-09-07 |
4 |
AS |
$42.29 |
$2,118,846 |
D/D |
(50,000) |
537,160 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
President and CEO |
|
2021-10-04 |
4 |
AS |
$39.97 |
$2,004,390 |
D/D |
(50,000) |
537,160 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
President and CEO |
|
2021-11-08 |
4 |
AS |
$39.62 |
$1,990,768 |
D/D |
(50,000) |
537,160 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-11-15 |
4 |
AS |
$54.11 |
$541,146 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-11-16 |
4 |
AS |
$53.90 |
$538,990 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-11-17 |
4 |
AS |
$52.15 |
$521,490 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-12-13 |
4 |
AS |
$58.64 |
$586,627 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-12-14 |
4 |
AS |
$58.30 |
$582,980 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2022-12-15 |
4 |
AS |
$57.29 |
$573,694 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-01-17 |
4 |
AS |
$50.40 |
$504,539 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-01-18 |
4 |
AS |
$51.05 |
$510,470 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-01-19 |
4 |
AS |
$52.41 |
$524,140 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-02-07 |
4 |
AS |
$51.26 |
$512,580 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-02-08 |
4 |
AS |
$51.36 |
$513,570 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-02-09 |
4 |
AS |
$50.40 |
$504,000 |
D/D |
(10,000) |
587,177 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-03-07 |
4 |
AS |
$45.47 |
$454,690 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-03-08 |
4 |
AS |
$43.26 |
$432,590 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-03-09 |
4 |
AS |
$42.73 |
$427,270 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-07-25 |
4 |
AS |
$42.80 |
$427,960 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-07-26 |
4 |
AS |
$42.69 |
$426,890 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-07-27 |
4 |
AS |
$43.79 |
$437,900 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-08-15 |
4 |
AS |
$43.77 |
$437,680 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-08-16 |
4 |
AS |
$43.53 |
$435,320 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-08-17 |
4 |
AS |
$43.18 |
$431,820 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
169 Records found
|
|
Page 2 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|